Vol.

No.

March 24, 2023Mar 24, 2023

DOWNLOAD THE PDF

ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved

Cover Story

Cancer History Project Free

ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved

By Paul Goldberg

Jed Manocherian wants your attention—but not for himself.

Cancer History Project Conversation with The Cancer Letter Free

Jed Manocherian grew obsessed with Mary Lasker after starting an NIH lobbying organization

By Paul Goldberg

Cancer History Project Conversation with The Cancer Letter Free

Lasker Foundation’s Claire Pomeroy: “Mary’s story truly has been an untold story”

By Paul Goldberg

NCI

Bertagnolli to announce National Cancer Plan that would “align broad societal engagement” to reduce cancer mortality

By Matthew Bin Han Ong

Free In the Archives

Contributor spotlight: FDA Oncology Center of Excellence

In Brief

Patricia M. LoRusso elected AACR president-elect for 2023-2024

ACS receives $4M from Genentech to drive health equity

Stephen Klasko and Colleen Wyse to fund a ACS research program to improve access to quality care

Crystal Mackall to receive the Edward Netter Leadership Award for cancer immunotherapy contributions

ACCC releases 2022 Impact Report

Florencia McAllister to receive TAMEST Mary Beth Maddox Award for pancreatic tumor microbiome research

Clinical Roundup

Study reveals link between major discrimination and frailty in African American cancer survivors

Sylvester investigators find disparities in mesothelioma survival due to social determinants, limited access

Sylvester researchers identify neutrophils as major factor in treatment resistance of pancreatic cancer

USC study on mutation linked to leukemia could lead to a way to identify patients most at risk

Yale physicians using new technology to diagnose lung cancer

Drugs & Targets

FDA releases draft guidance aimed at improving oncology clinical trials for accelerated approval

FDA grants accelerated approval to Zynyz for metastatic or recurrent locally advanced Merkel cell carcinoma

ACS & Winship Cancer Institute partner to accelerate cancer research in Georgia

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

ACT for NIH publishes Mary Lasker biography to use in lobbying for appropriations—Mary would’ve approved

Jed Manocherian grew obsessed with Mary Lasker after starting an NIH lobbying organization

Lasker Foundation’s Claire Pomeroy: “Mary’s story truly has been an untold story”

Bertagnolli to announce National Cancer Plan that would “align broad societal engagement” to reduce cancer mortality

Contributor spotlight: FDA Oncology Center of Excellence

In Brief

Patricia M. LoRusso elected AACR president-elect for 2023-2024

ACS receives $4M from Genentech to drive health equity

Stephen Klasko and Colleen Wyse to fund a ACS research program to improve access to quality care

Crystal Mackall to receive the Edward Netter Leadership Award for cancer immunotherapy contributions

ACCC releases 2022 Impact Report

Florencia McAllister to receive TAMEST Mary Beth Maddox Award for pancreatic tumor microbiome research

Clinical Roundup

Study reveals link between major discrimination and frailty in African American cancer survivors

Sylvester investigators find disparities in mesothelioma survival due to social determinants, limited access

Sylvester researchers identify neutrophils as major factor in treatment resistance of pancreatic cancer

USC study on mutation linked to leukemia could lead to a way to identify patients most at risk

Yale physicians using new technology to diagnose lung cancer

Drugs & Targets

FDA releases draft guidance aimed at improving oncology clinical trials for accelerated approval

FDA grants accelerated approval to Zynyz for metastatic or recurrent locally advanced Merkel cell carcinoma

ACS & Winship Cancer Institute partner to accelerate cancer research in Georgia

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login